Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when MAIA files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: MAIA MAIA Biotechnology, Inc. 8-K

MAIA shareholders re-elect directors, ratify auditor at 2026 annual meeting

Filed May 22, 2026 · Period ending May 21, 2026 · ~1 min read

3 key changes 1 section

Key Changes

  • medium

    Director Louie Ngar Yee re-elected despite 34.6% withhold votes (8,796,832 withheld vs 16,658,677 for), suggesting shareholder concern though nominee secured majority support.

    Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
  • low

    Director Steven Chaouki re-elected with 98.6% support (25,109,811 for vs 345,698 withheld), reflecting strong shareholder confidence.

    Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
  • low

    Grant Thornton LLP ratified as auditor with 99.4% approval (37,278,294 for vs 210,408 against), a routine outcome.

    Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →

Summary

MAIA held its 2026 annual meeting on May 21, achieving quorum with 61.88% of outstanding shares represented (37,547,754 of 60,671,491 shares). Both Class I director nominees were re-elected for three-year terms, though with notably different levels of support. Steven Chaouki received strong backing at 98.6% of votes cast, while Louie Ngar Yee faced elevated opposition with 34.6% of votes withheld—still passing but suggesting some shareholders have concerns about this director's continued service.

The auditor ratification passed with 99.4% approval, a routine result. For retail holders, the key takeaway is the split outcome in director voting: Chaouki's near-unanimous support versus the meaningful withhold rate for Ngar Yee. While both directors were re-elected and the company's governance continues unchanged, the Ngar Yee result may reflect shareholder views on board composition or performance worth monitoring in future proxy cycles.

Section-by-Section Diff

Event · Item 5.07 — Submission of Matters to a Vote of Security Holders

~400 words

MAIA held its 2026 annual meeting, re-electing two Class I directors and ratifying Grant Thornton as auditor.

2 Added
Added Class I director elections medium

Added in current filing · verify on EDGAR →

Directors | For | Withheld | Broker | Non-Votes | Louie Ngar Yee | 16,658,677 | 8,796,832 | 11,375,414 | Steven Chaouki | 25,109,811 | 345,698 | 11,375,414

Both Class I director nominees were re-elected for three-year terms. Steven Chaouki received strong support with 98.6% of votes cast (25,109,811 for vs 345,698 withheld), representing 41.4% of shares outstanding. Louie Ngar Yee received 65.4% of votes cast (16,658,677 for vs 8,796,832 withheld), representing 27.5% of shares outstanding. The elevated withhold votes for Ngar Yee (34.6% of votes cast) suggest some shareholder concern, though the nominee was still re-elected.

Show 1 minor / wording change
Added Annual meeting quorum and attendance low

Added in current filing · verify on EDGAR →

As of the record date of March 23, 2026, there were 60,671,491 shares of the Company’s common stock issued and outstanding and entitled to vote at the Annual Meeting. At the Annual Meeting, there were present, in person or by proxy, shareholders holding an aggregate of 37,547,754 shares of common stock, representing approximately 61.88% of the shares of common stock issued and outstanding and entitled to vote at the Annual Meeting; therefore a quorum was present.

The annual meeting achieved quorum with 61.88% of outstanding shares represented (37,547,754 of 60,671,491 shares). This is a routine shareholder turnout for a small-cap biotech company.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Jun 21, 2026 · How we verify